KOE:340570

T&L Co., Ltd. · KOE · Healthcare · KRW · FY for 2024

Figures on this page computed 2026-11-08 13:18 UTC

Last close

n/aKRW

Market data

  • 8.1xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2024
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • 26.5%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • 17.2%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Five bars, one line

lens 7 of 9
2.45x
2.63x
3.27x
0.25x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2024
Computed2024
Computed2024
Computed2024
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2024

  • Sales2.45x

    Its own average over 8 years, 71.25B.

  • Profit2.63x

    Its own average over 8 years, 17.67B.

  • Free cash flow3.27x

    Its own average over 7 years, 9.21B.

  • Debt0.25x

    Its own average over 8 years, 1.84B.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 3.27 times.

Sales is 2.45 times its own 8-year average; Profit is 2.63 times its own 8-year average; Free cash flow is 3.27 times its own 7-year average; Debt is 0.25 times its own 8-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

  • Sales against its own 8-year average2.45
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    KRW
  • Profit against its own 8-year average2.63
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    KRW
  • Free cash flow against its own 7-year average3.27
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    KRW
  • Debt against its own 8-year average0.25
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    KRW
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.